Key result
High-dose vigabatrin achieved higher rates of spasm cessation compared to low-dose vigabatrin in patients with newly diagnosed infantile spasms.
Why the study?
Does high-dose vigabatrin improve spasm cessation compared to low-dose vigabatrin in infants with newly diagnosed infantile spasms?
RCT (n=221)
Single-blind
Does high-dose vigabatrin improve spasm cessation compared to low-dose vigabatrin in infants with newly diagnosed infantile spasms?
High-dose vigabatrin is more effective than low-dose vigabatrin for achieving rapid spasm cessation in infants with newly diagnosed infantile spasms.
Answers are grounded in this paper and cite their sources.
May favor high-dose vigabatrin for infantile spasms; leaves open confirmation of optimal dosing and outcomes in larger trials.
A large randomized study was conducted in patients with newly diagnosed infantile spasms to compare 2 doses of vigabatrin in achieving spasm cessation. High (100-148 mg/kg/d) and low (18-36 mg/kg/d) oral doses of vigabatrin were evaluated in a randomized, single-blind study of 14 to 21 days with subsequent open-label treatment up to 3 years. Spasm cessation was defined as 7 consecutive days of spasm freedom beginning within the first 14 days, confirmed by video-electroencephalogram. A total of 221 subjects comprised the modified intent-to-treat cohort. More subjects in the high-dose group achieved spasm cessation compared with the low-dose vigabatrin group (15.9% [17/107] vs 7.0% [8/114]; P = .0375). During follow-up, 39 of 171 (23%) subjects relapsed; 28 of 39 (72%) regained spasm freedom. Adverse events were primarily mild to moderate in severity. Vigabatrin had a dose-dependent effect in spasm reduction. Spasm cessation occurred rapidly and was maintained in the majority of infants.
No takes yet. Share an insight, caveat, or question.
Elterman et al. (2010) conducted an RCT in Infantile spasms (n=221). Vigabatrin vs. Low dose vigabatrin (18-36 mg/kg/d) was evaluated on Spasm cessation (7 consecutive days of spasm freedom beginning within the first 14 days, confirmed by video-electroencephalogram) (p=0.0375). High-dose vigabatrin achieved higher rates of spasm cessation compared to low-dose vigabatrin in patients with newly diagnosed infantile spasms.
Synapse has enriched 10 related papers. Consider them for comparative context: